Young-Seung Ko

Dr. Young-Seung Ko

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2023 in Hip & Pelvis
Verified
Journal Article
Open access
PDF file
YKYoung-Seung Ko
Young-Seung Ko
JHJoo Hyung Ha
Joo Hyung Ha
JPJung-Wee Park
Jung-Wee Park
YLYoung-kyun Lee
Young-kyun Lee
TKTae-Young Kim
Tae-Young Kim
KKKyung-Hoi Koo
Kyung-Hoi Koo
Ko YS, et al. Hip Pelvis. 2023 Sep;35(3):147-156. https://doi.org/10.5371/hp.2023.35.3.147

31 October 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BYByung-Ho Yoon
Byung-Ho Yoon
TKTae-Young Kim
Tae-Young Kim
YKYoung-Seung Ko
Young-Seung Ko
YLYoung-Kyun Lee
Young-Kyun Lee
TKTae-Young Kim
Tae-Young Kim
KKKyung-Hoi Koo
Kyung-Hoi Koo
Tranexamic acid (TXA) has been demonstrated to minimize blood loss after total hip arthroplasty. There are three main routes: intravenous (IV), intra-articular (topical), and combined (IV and topical) but little consensus support which is most effective and safe. We performed network meta-analysis.to assess the comparative efficacy and safety of three different administration routes of TXA. Twenty-five randomized controlled trials (RCT) were evaluated. Interventions were classified as: combined, IV multiple, IV single, topical and placebo. The primary outcome was effectiveness (transfusion rate, total blood loss, and total drain out). The secondary outcome was safety, based on the incidence of deep venous thrombosis (DVT) and pulmonary embolism (PE). A total of 2227 patients were included in the 5 categories: 564 IV single, 319 IV multiple, 398 topical, 120 combined, and 826 placebo. A network meta-analysis identified the most effective interventions in terms of reducing the need for transfusion as follows: combined = 98.2%, IV single = 54.0%, IV multiple = 78.6%, topical = 66.1%, placebo = 0.0%. Compared with placebo, the IV single, IV multiple, topical, and combined interventions showed no difference in the rate of occurrence of DVT and PE. A network meta-analysis indicated that combined administration of TXA (IV and topical) was effective in reducing the transfusion rate after hip arthroplasty compared with IV or topical alone. As no high-risk patients were evaluated in the RCTs, it is not known whether the combined method is safer for patients susceptible to DVT or PE.

22 March 2023 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
JPJung-Wee Park
Jung-Wee Park
YKYoung-Seung Ko
Young-Seung Ko
YLYoung-kyun Lee
Young-kyun Lee
YHYong-Chan Ha
Yong-Chan Ha
KKKyung-Hoi Koo
Kyung-Hoi Koo
Background: We previously reported mid-term results of total hip arthroplasty (THA) using Delta ceramic-on-ceramic (CoC) bearings in 72 patients (86 hips) who were 10 years after THA using Delta CoC bearings in patients who were <30 years old. Methods: Cementless THA with a Delta CoC bearing was performed between March 2008 and January 2012 in 91 hips of 76 patients who were <30 years old. Eighty-five hips in 71 patients (44 men and 27 women) with a mean age of 25.9 years (range, 16 to 29 years) at surgery were followed for a mean of 10.9 years (range, 10 to 13 years). Results: No ceramic bearings fractured. The incidence of squeaking increased to 5.9% (5 of 85), but the squeaking was not reproducible within individual patients. Periprosthetic osteolysis developed in 3 hips (3 patients): around the stem in 2 and around the metal shell in 1. The stem in 1 hip underwent revision because of a Vancouver type-B2 periprosthetic femoral fracture. One patient with systemic lupus erythematosus underwent irrigation and debridement for periprosthetic joint infection. Survivorship free of reoperation for any reason was 92.4% (95% confidence interval, 82.4% to 100%) at 13 years. Conclusions: The long-term results and survivorship of Delta CoC THA in patients <30 years old were favorable. Level of Evidence: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.

Verified
Journal Article
Open access
PDF file
YKYoung-Seung Ko
Young-Seung Ko
SKSang Yoon Kang
Sang Yoon Kang
HLHan Jin Lee
Han Jin Lee
HKHong Seok Kim
Hong Seok Kim
JYJeong Joon Yoo
Jeong Joon Yoo
Background: Since the turn of the century, the age-adjusted incidence of proximal femoral fractures has caused a plateau or fall. However, it was anticipated that the number of patients with proximal femoral fractures would rise as life expectancy rose and the population over 80 years old expanded. The aim of this study was to compare the length of hospital stay, complication rate, and mortality in patients with proximal femoral fractures between two different time periods: 20 years ago and the present. Methods: We conducted a retrospective review of medical records of patients aged 65 years and above who underwent surgery for proximal femoral fractures between January 2000 and December 2001 and between January 2020 and December 2021. We collected information on age, gender, fracture type, length of hospital stay, and complication rate. Dates of death were obtained from the Ministry of the Interior and Safety. Results: We included 136 patients who were operated on between 2000 and 2001 and 134 patients between 2020 and 2021. The average age increased significantly from 71.6 years to 79.0 years (p < 0.001). The length of hospital stay decreased dramatically from 15.1 days to 6.0 days (p < 0.001). There was no statistically significant difference in delirium, urinary tract infection, or pneumonia. No difference was found in 30-day or 1-year mortality between the two groups. Conclusions: The complication rate and mortality between the two time periods appeared comparable, although the length of hospital stay decreased substantially. Therefore, we recommend considering expedited discharge from the acute care hospital for elderly hip fracture patients while implementing an individualized approach for better outcomes.

31 August 2022 in Journal of Bone Metabolism
Verified
Journal Article
Open access
PDF file
YKYoung-Seung Ko
Young-Seung Ko
YJYeonsuk Jeong
Yeonsuk Jeong
JPJung-Wee Park
Jung-Wee Park
YLYoung-kyun Lee
Young-kyun Lee
KKKyung-Hoi Koo
Kyung-Hoi Koo
Background: The Korean National Health Insurance (NHI) reimbursement guideline was revised in May 2015 with the aim of preventing secondary osteoporotic fractures. Here we compared the: (1) rate of bone mineral density (BMD) measurements; (2) prescription rate of anti-osteoporosis medication within 3 months after hip fracture surgery (HFS); (3) incidence of a second hip fracture; and (4) first-year mortality rate after HFS.Methods: This before-after study used the revised reimbursement system as a reference period. We retrospectively reviewed the medical records of 515 patients who underwent HFS at a tertiary referral hospital between January 2014 and December 2016. The period 1 group underwent HFS in 2014, while the period 2 group underwent HFS in 2016.Results: Despite the fact that there was no significant intergroup difference in BMD measurement rate, the period 2 group had a higher prescription rate for anti-osteoporosis drugs within 3 months of HFS. However, the incidence of a second hip fracture did not differ between groups. The first-year mortality rate was higher in the period 1 versus period 2 group.Conclusions: Revision of the NHI guideline in May 2015 was associated with an increased prescription rate of anti-osteoporosis medication in osteoporotic hip fracture patients.

1 January 2024 in Clinics in Orthopedic Surgery
Verified
Journal Article
Open access
PDF file
YKYoung-Seung Ko
Young-Seung Ko
SKSang Yoon Kang
Sang Yoon Kang
HKHong Seok Kim
Hong Seok Kim
JYJeong Joon Yoo
Jeong Joon Yoo
Ko YS, et al. Clin Orthop Surg. 2024 Jun;16:e41. https://doi.org/10.4055/cios23377